Metohexal



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 100.0%
Blood Pressure Increased 33.3%
Drug Interaction 33.3%
Polyp 33.3%
Secondary
Hypertension 34.7%
Coronary Artery Disease 8.4%
Atrial Fibrillation 7.4%
Multiple Drug Overdose 7.4%
Product Used For Unknown Indication 6.3%
Cardiac Failure 4.2%
Pain 4.2%
Diabetes Mellitus 3.2%
Infection Prophylaxis 3.2%
Arrhythmia 2.1%
Breast Cancer 2.1%
Constipation 2.1%
Essential Hypertension 2.1%
Infection 2.1%
Myocardial Infarction 2.1%
Osteoarthritis 2.1%
Renal Failure 2.1%
Thrombosis Prophylaxis 2.1%
Anticoagulant Therapy 1.1%
Candidiasis 1.1%
Hypertensive Crisis 14.3%
Intentional Self-injury 9.5%
Sinoatrial Block 9.5%
Stevens-johnson Syndrome 9.5%
Syncope 9.5%
Accommodation Disorder 4.8%
Blood Pressure Increased 4.8%
Bradycardia 4.8%
Drug Interaction 4.8%
Nausea 4.8%
Skin Fissures 4.8%
Tachycardia 4.8%
Toxic Epidermal Necrolysis 4.8%
Vomiting 4.8%
Weight Increased 4.8%
Concomitant
Hypertension 30.7%
Product Used For Unknown Indication 19.0%
Drug Use For Unknown Indication 10.0%
Rheumatoid Arthritis 7.8%
Depression 3.3%
Type 2 Diabetes Mellitus 3.2%
Atrial Fibrillation 2.9%
Prophylaxis 2.6%
Diabetes Mellitus 2.5%
Coronary Artery Disease 2.2%
Pain 2.2%
Osteoporosis 1.9%
Myocardial Infarction 1.7%
Breast Cancer 1.6%
Diffuse Large B-cell Lymphoma 1.6%
Hyperlipidaemia 1.6%
Hypothyroidism 1.4%
Prostate Cancer 1.4%
Diabetic Neuropathy 1.2%
Renal Transplant 1.2%
Vomiting 7.4%
Myocardial Infarction 6.5%
Syncope 6.5%
Vertigo 6.5%
Cardiac Failure 5.6%
Hypertensive Crisis 5.6%
Nausea 5.6%
Weight Increased 5.6%
Cerebrovascular Accident 4.6%
Death 4.6%
Malaise 4.6%
Pancreatitis Acute 4.6%
Sepsis 4.6%
Tibia Fracture 4.6%
Urinary Tract Infection 4.6%
Convulsion 3.7%
Dermatitis Allergic 3.7%
Dyspnoea 3.7%
Long Qt Syndrome 3.7%
Pneumonia 3.7%
Interacting
Drug Use For Unknown Indication 25.0%
Sedation 25.0%
Coronary Artery Disease 16.7%
Gastrointestinal Disorder 16.7%
Lipids 16.7%
Somnolence 66.7%
Drug Interaction 16.7%
Sudden Death 16.7%